Sociodemographic Factors Associated With High-Risk Human Papillomavirus Infection
- 1 July 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 110 (1) , 87-95
- https://doi.org/10.1097/01.aog.0000266984.23445.9c
Abstract
OBJECTIVE: To determine the prevalence of high-risk (cancer-associated) human papillomavirus (HPV) infection in U.S. women, identify sociodemographic factors associated with infection, and explore the implications for prevention of HPV-related disease in the vaccination era. METHODS: Women aged 14–59 years (n=1,921) participating in the 2003–2004 National Health and Nutrition Examination Survey provided a vaginal swab which was evaluated for 37 HPV types. We determined which sociodemographic characteristics were associated with high-risk HPV, using logistic regression models. RESULTS: High-risk HPV infection was present in 15.6% (95% confidence interval [CI] 12.6–18.6%) of participants, corresponding to a population prevalence of 12,028,293 U.S. women. Women living below the poverty line, compared with those living three or more times above it, were more likely to be positive for high-risk HPV (23% versus 12%, P = .03). Among participants living below the poverty line, only Mexican-American ethnicity (odds ratio [OR] 0.4, 95% CI 0.2–0.9) and unmarried status (OR 3.3, 95% CI 1.2–8.9) were associated with HPV prevalence. In contrast, several factors were associated with HPV among participants living above the poverty line, including black race (OR 1.4, 95% CI 1.0–2.0), income (OR 0.92, 95% CI 0.84–0.99), unmarried status (OR 2.0, 95% CI 1.3–3.0), and age (OR for 22–25 year olds 2.4, 95% CI 1.4–4.0). CONCLUSION: High-risk HPV infection is common in U.S. women, particularly in poor women. Cervical cancer prevention efforts in the vaccination era must ensure that all low-income women have access to preventive services including education, Pap test screening, and HPV vaccines. Otherwise, existing disparities in cervical cancer could worsen. LEVEL OF EVIDENCE: IIIKeywords
This publication has 20 references indexed in Scilit:
- Human papillomavirus genotyping using a modified linear array detection protocolJournal of Virological Methods, 2006
- Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialThe Lancet, 2006
- Analysis of the Effect of DNA Purification on Detection of Human Papillomavirus in Oral Rinse Samples by PCRJournal of Clinical Microbiology, 2005
- Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic reviewInternational Journal of STD & AIDS, 2005
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialThe Lancet Oncology, 2005
- A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent WomenThe Journal of Infectious Diseases, 2005
- A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccineInternational Journal of Cancer, 2003
- The Anatomy of a Disparity in Infant MortalityAnnual Review of Public Health, 2003
- Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, black, Hispanic, and white residents of the San Francisco Bay Area, 1988–92 (United States)Cancer Causes & Control, 1999
- Contribution of socioeconomic status to black/white differences in cancer incidenceCancer, 1989